复方牛胎肝提取物治疗非酒精性脂肪肝临床观察

doi:10.3969/j.issn.1672-5069.2014.03.027

Abstract

Feng Kaiyu. Efficacy of compound embryonic bovine liver extract in the treatment of patients with non-alcoholic fatty liver[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(3): 311-313.

[1] Alisi A,Cianfarani S,Manco M,et al. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents:pathogenetic role of genetic background and intrauterine environment. Ann Med,2012,44（1）:29-40.
[2] 浙江省脂肪肝和酒精肝协作组.复方牛胎肝提取物治疗非酒精性脂肪性肝病的多中心临床研究.临床肝胆病杂志,2011,27（2）:166-173 .
[3] 沈峰,丁晓东,范建高. 美国非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2012,15（4）:362-363.
[4] 王春霞,麦韵屏, 沙卫红,等. 体检人群非酒精性脂肪性肝病检出率及其相关因素分析. 实用肝脏病杂志,2012,15（4）:289-290.
[5] Souza MR,Diniz MF,Medeiros-Filho JE,et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol,2012,49（1）:89-96.
[6] 谭彦芳, 赵彩彦. 非酒精性脂肪肝病药物治疗进展.实用肝脏病杂志,2013,16（4）:378-381.
[7] Alisi A,Nobili V. Non-alcoholic fatty liver disease in children now:lifestyle changes andpharmacologic treatments. Nutrition,2012,28（8）:722-726.
[8] Yilmaz Y. Fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther,2012,35（10）:1135-1144.
[9] 黄卫东, 高卓维, 殷鑫, 等.肝脂平联合复方牛胎肝提取物片治疗非酒精性脂肪肝的临床观察. 湖北中医杂志,2010,32（12）:13-14.
[10] 李烨,黄腊平,彭红兵,等. 非酒精性脂肪肝的中西医结合治疗.中国临床实用医学,2010,4（1）:199-201.
[11] Gressner OA,Weiskirchen R,Gressner AM. Biomarkers of liver fibrosis:clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta,2007,381（2）:107-113.
[12] Juriens I,Rigaux J,Blero D. Nonalcoholic fatty liver disease assessment. Rev Med Brux,2012,33（4）:205-211.
[13] 蔡卫民, 陶君, 张彬彬, 等.复方牛胎肝提取物片抗肝纤维化的实验研究. 中华肝脏病杂志,2004,12（8）:499.
[14] Chuthan SA,Pagadala MR,Kirwan JP. Management of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol,2013,59（1）:69-87.
[15] Martinson BC,Crain AL,Sherwood NE,et al. Population reach and recruitment bias in a maintenance RCT in physically active older adults. J Phys Act Health, 2010,7（1）:127-135.

Efficacy of compound embryonic bovine liver extract in the treatment of patients with non-alcoholic fatty liver

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[2]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[3]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[4]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[5]	Zhang Zhicheng, Yuan Guangqi, Mo Chanjun. Impact of blood supply on efficacy of hepatic artery embolization in treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2019, 22(5): 736-739.
[6]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[7]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[8]	Yuan Chunhui, Li Chunyu, Li Hongli. Efficacy of pegylated interferon α -2b in the treatment of patients with serum HBeAg positive chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 353-356.
[9]	Fu Liang, Wu Dongbing, Ji Xinzun. Application of ARFI quantification in the evaluation of liver injuries in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 377-380.
[10]	Ma Xiaosu, Pei Renming Zhang Tingting. Comparison of magnetic resonance cholangiopancreatography with color Doppler ultrasound in diagnosis of patients with common bile duct stones [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 433-436.
[11]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[12]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[13]	Su Shuting, Zhong Yan, Mi Yuqiang.. Management of patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 293-296.
[14]	Zhang Feng, Yan Yan.. Implication of serum apolipoprotein B levels and its correlation with metabolic syndrome in checked-up individuals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 61-64.
[15]	Song Na, Liu Xiaoyan, Liu Chang, et al.. Changes of plasma thyrotropin levels in patients with nonalcoholic fatty liver disease and type 2 diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 65-68.